HeartBeam's Upcoming Conference Call for Financial Results
HeartBeam, Inc. (NASDAQ: BEAT) is set to host a conference call to discuss its third-quarter results. This event will occur on a Thursday afternoon in November, where the leadership team aims to provide insights into the results for the quarter ending September 30. The main focus will be on detailing financial outcomes, regulatory updates, ongoing initiatives, and all anticipated milestones.
Key Leaders from HeartBeam
Hosting this significant conference call will be HeartBeam CEO Robert Eno, alongside Founder and President Branislav Vajdic, PhD, and CFO Timothy Cruickshank. Their experiences and insights into the company's progress promise to enrich the conversation, leading into a Q&A session where they will address questions from participants.
How to Join the Conference Call
For those interested in participating, joining the call is straightforward. Listed below is the essential information:
Date: Thursday, November 7
Time: 4:30 p.m. Eastern Time (1:30 p.m. Pacific Time)
Dial-in Number: 1-800-717-1738
International Dial-in: 1-646-307-1865
Conference Code: 1101650
Participants can also attend via the webcast, which will accompany the audio portion of the call. Accessibility will be available through a dedicated link released before the event.
Replay and Further Information
If you miss the live broadcast, a telephone replay will be available approximately three hours after the call and will be accessible until early February of the following year. Those interested in the replay can dial 1-844-512-2921 from the U.S. or 1-412-317-6671 from international locations. Make sure to use the same conference code as for the live call.
About HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ: BEAT) is dedicated to revolutionizing cardiac care through advanced medical technology. The company's innovative approach includes developing a cable-free 12-lead ECG, capable of providing comprehensive data on the heart's electrical activity from three dimensions. This groundbreaking device is designed to be portable, allowing patients to receive instantaneous insights about their heart health in various circumstances.
By equipping healthcare providers with actionable intelligence, HeartBeam aims to enhance the ability to monitor health trends and identify acute cardiac conditions outside traditional medical settings. This approach heralds a transformative shift in how cardiac health will be managed, ensuring that patients have access to immediate care recommendations.
HeartBeam's Commitment to Innovation
With a focus on using patented technology, HeartBeam holds numerous issued patents designed to facilitate its mission. Fueled by a vision for improved patient outcomes, the organization is consistently working on novel solutions in cardiac diagnostics that prioritize convenience and accuracy.
Frequently Asked Questions
What is the date and time of HeartBeam's conference call?
The conference call is scheduled for Thursday, November 7, at 4:30 p.m. Eastern Time.
Who will lead the conference call?
The call will be led by HeartBeam's CEO, Robert Eno, alongside other key leaders of the company.
How can I participate in the conference call?
You can participate by dialing the given numbers or joining the webcast link that will be provided prior to the call.
Will there be a replay available?
Yes, a replay of the conference call will be available approximately three hours after it concludes, lasting until early February.
What is HeartBeam known for?
HeartBeam, Inc. is recognized for its innovative solutions in cardiac care, specifically its cable-free 12-lead ECG technology designed to enhance patient experiences in monitoring heart health.
